Current and Future Therapies for Hepatitis C Virus Infection


Ozaras R. , Yemisen M., Balkan I. I.

NEW ENGLAND JOURNAL OF MEDICINE, cilt.369, ss.679, 2013 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 369 Konu: 7
  • Basım Tarihi: 2013
  • Dergi Adı: NEW ENGLAND JOURNAL OF MEDICINE
  • Sayfa Sayısı: ss.679

Özet

To the Editor: In their review of drug therapy for chronic hepatitis C infection, Liang and Ghany (May 16 issue)(1) summarize boceprevir- and telaprevir-based regimens. Figure 2 of the article describes the regimens according to the response to the previous therapy, the response-guided therapy, and the stopping rules. The boceprevir regimen they describe represents the labeling information in the United States.(2) However, the information about boceprevir in European regimens has some differences(3) the duration of therapy for patients who have not had a response to previous therapy (whether the patient had a relapse, a partial response, or no response) ...